- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03814863
China Red Eye Study (CRES)
April 11, 2020 updated by: Xiaofeng Lin, Sun Yat-sen University
This study intends to use a hospital-based multi-center cross-sectional study to understand the disease composition of "red-eye" patients in Chinese ophthalmology clinics.
This study will provide important clinical diagnosis and treatment data for common eye diseases in China with "red eye" as the main performance.
Study Overview
Status
Completed
Conditions
Detailed Description
Red eye is a common sign of eye diseases.
Eye diseases such as ocular surface inflammation, glaucoma, and uveitis can be expressed as red eyes.
The disease with red eye as the main complaint is the most common condition that clinicians need to identify.
It is not uncommon to be misdiagnosed and missed clinically.
The collection and analysis of the disease composition of the "red eye" in Chinese ophthalmology clinics will help to understand the current status of "red eye" related diseases and provide a systematic and comprehensive clinical basis for the differential diagnosis of red eye.
Study Type
Observational
Enrollment (Actual)
4382
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Chengdu, China
- West China Hospital of Sichuan University
-
Dalian, China
- Affiliated Zhongshan Hospital of Dalian University
-
Kunming, China
- First Affiliated Hospital of Kunming Medical University and Hainan Eye Hospital
-
Nanning, China
- Nanxishan Hospital of Guangxi Zhuang Autonomous Region
-
Shanghai, China
- Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
-
Wuhan, China
- llege of Huazhong University of Science and Technology
-
Xinjiang, China
- The first affiliated hospital of Xinjiang medical university
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510000
- Zhongshan Ophthalmic Center of Sun yat-sen Universtiy
-
-
Hainan
-
Haikou, Hainan, China
- Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with "red eye".
Description
Inclusion Criteria:
- Confirmation of signs under the slit lamp is red eye
Exclusion Criteria:
- The investigator believes that there are any unsuitable reasons for participating in the trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
medical diagnosis of each patient
Time Frame: 1 day (when the patient come the the doctor)
|
the investigators record patients' diagnosis on questionnaire when the patient come to the doctor
|
1 day (when the patient come the the doctor)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2018
Primary Completion (Actual)
December 31, 2019
Study Completion (Actual)
December 31, 2019
Study Registration Dates
First Submitted
November 8, 2018
First Submitted That Met QC Criteria
January 23, 2019
First Posted (Actual)
January 24, 2019
Study Record Updates
Last Update Posted (Actual)
April 14, 2020
Last Update Submitted That Met QC Criteria
April 11, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- ZOC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Red Eye
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityRecruitingRed Laser Light-Induced Retinopathy of Both Eyes (Diagnosis)China
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedPure Red-cell AplasiaUnited Kingdom, Sweden, South Africa, Brazil, Canada, Germany, Norway, Thailand
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Bing HanCompletedPure Red Cell Aplasia, AcquiredChina
-
Population Health Research InstituteNot yet recruitingRed Blood Cell Transfusion
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingRed Blood Cell DisorderChina
-
University of British ColumbiaCompleted
-
Tel-Aviv Sourasky Medical CenterUnknownRed Blood Cells Transfusion.Israel
-
Heinrich-Heine University, DuesseldorfCompletedEndothelial Function | Red Blood Cells | Nitric Oxide Pool in Red Blood Cells and Blood PlasmaGermany
-
Haemonetics CorporationCompletedRed Blood Cell DonationUnited States